JASHMALYN LIMITED

Executive Summary

JASHMALYN LIMITED is a young, very small healthcare business operating with minimal financial reserves and working capital. Its financial condition is fragile, with just enough assets to cover liabilities, indicating a need for improved liquidity and capital support. Immediate focus on cash flow management and equity injection will improve its financial resilience and future prospects.

JASHMALYN LIMITED - Analysis Report

Company Number: 13804802

Analysis Date: 2025-07-29 20:42 UTC

Financial Health Assessment Report for JASHMALYN LIMITED

---

1. Financial Health Score: D

Explanation:
JASHMALYN LIMITED’s financial data reveals a company that is technically solvent but operating on the bare minimum in terms of net assets and working capital. The score "D" reflects a fragile financial condition, akin to a patient with critical but manageable symptoms — stable for now but at risk without intervention.

---

2. Key Vital Signs

Metric	Latest Value (2024)	Interpretation
Current Assets	£1,996	Very low liquidity; limited cash or receivables available
Current Liabilities	£1,995	Nearly equal short-term obligations, indicating tight cash flow
Net Current Assets	£1	Essentially no working capital surplus, high risk of distress
Net Assets (Shareholders Funds)	£1	Minimal equity base, indicating very thin financial buffer
Employee Count	1	Very small operation, low overhead
Company Age	3 years (incorporated Dec 2021)	Young company, early development phase

Interpretation:
The company’s “vital signs” indicate a precarious financial position. The net current assets of just £1 suggest the company can only just cover its short-term liabilities with its current assets, leaving no margin for unexpected expenses or downturns. The net assets of £1 imply no retained earnings or capital cushion, a symptom akin to a patient with a dangerously low reserve of red blood cells — operational but vulnerable.

---

3. Diagnosis

• Liquidity Status: The company shows symptoms of tight liquidity, with current assets barely covering current liabilities. This means cash flow is likely very constrained, and the company must manage payables and receivables meticulously to avoid distress.

• Capital Structure: The extremely low net asset base suggests that the company has not yet built up retained profits or invested capital, typical for a micro-entity in early stages but a risk factor if losses occur.

• Operational Scale: With only one employee and classified under health care activities (residential nursing care, hospital activities), the business is likely small-scale, possibly a sole practitioner or small care provider.

• Growth and Sustainability Risks: Without a financial buffer, the company is at risk of “financial shock” from any unexpected expenses or revenue shortfalls. It is akin to a patient with no reserve immune strength—any infection (financial stress) could be critical.

---

4. Recommendations

• Enhance Cash Reserves: Aim to build net current assets by increasing cash or receivables relative to short-term liabilities. This might involve better credit control or renegotiating payment terms with suppliers.

• Increase Capital Injection: Consider an equity injection from the shareholder (Mr. Junbert Aguirre) to provide a buffer and enable investment in growth or operational improvements.

• Cost Management: Maintain tight control of costs given the narrow financial margins. Avoid unnecessary expenditure and seek efficiency wherever possible.

• Revenue Growth: Explore opportunities to increase turnover in the healthcare niche, possibly through expanding services or client base, to move beyond the micro-entity scale and build retained earnings.

• Regular Financial Monitoring: Implement monthly cash flow forecasts and management accounts to detect early signs of distress and react swiftly.

• Contingency Planning: Develop a contingency plan for liquidity crises, including access to short-term credit or other financing options.

---

Medical Analogy Summary

JASHMALYN LIMITED currently exhibits the “symptoms” of a financial patient with minimal reserves and borderline liquidity — stable but at risk. Without intervention to strengthen cash flow and capital, the company’s “health” could deteriorate rapidly under stress. Proactive management and capital support are essential to recovery and sustainable growth.

---